The downside is its poor bioavailability which results to a poor conversion rate of just 1% of the free cyanocobalamin
Duration of Study: Short-term acute studies (e.g., 24-48 hours) will naturally have a different 5-Amino-1MQ dosage profile than long-term chronic studies (e.g., 4-12 weeks)
- This research blend combines 100MG NAD+, 10MG MOTS-c, and 10MG 5-Amino-1MQ in a metabolic pathway-focused format studied in models involving cellular energy metabolism, mitochondrial signaling, NNMT pathway activity, NAD+-related biology, metabolic flexibility, and body-composition pathway research
However, none of the studies reported on hematological or clinical outcomes
Subcutaneous injection (into fat tissue) is commonly used for amounts less than 0.5 mL
The age-related drop in NAD+ levels is caused by rising levels of CD38, a membrane-bound NADase that degrades both NAD+ and its precursor nicotinamide mononucleotide, according to a 2016 study in mice, which exhibit age-related declines in NAD+ levels similar to those seen in humans (7)